Skip to main content
. Author manuscript; available in PMC: 2008 Dec 17.
Published in final edited form as: Vaccine. 2007 Nov 5;25(52):8687–8701. doi: 10.1016/j.vaccine.2007.10.030

Figure 2.

Figure 2

Enteric-coated HPMC capsule dissolution curve. Coated HPMC capsules with 13.2% w/w total solid polymer dispersion formulation of 4:1 Eudragit® L100 and Eudragit® S100 were subjected to dissolution test at 37ºC in 0.05 M sodium phosphate buffers of varying pH for the indicated times and the supernatant was assayed for A) dye release by spectrophotometry or B) virus release by real-time PCR. Results are presented as the means of samples performed in triplicate, and error bars represent the standard deviation.